1. 1. Gali Halevi & Henk F.Moed,“Evolution of BigData as Research and Scientific Topic: overview of literature”,in Biometrices, September 2012.
   2. Kuo lane Chen, Huei Lee, “The Impact of BigData on the Healthcare Information system Transcation of the International Confrence on health information technology advanvement,2013
   3. T R Prajwala, “ A comparative study on Decision Tree and Random forest using R tool”, IJRCCE,vol.4, issue 1, Janauary 2015.
   4. Olusegun Adekanle, A.Dennis, Samuel Anu Olowookere Oluwasegun Ijarotimi, and Kayode Thaddeus Ijadunola,“Knowledge of Hepatitis B Virus Infection Immunization with Hepatitis B Vaccine, Risk Perception, and Challenges to Control Hepatitis among Hospital Workers in a Nigerian Tertiary Hospital”,Volume 2015 (2015), Article ID 439867, 6 pages.
   5. Sara Romani, Seyed Masoud Hosseini, Seyed Reza Mohebbi Shabnam Kazemian, Shaghayegh Derakhshani, Mahsa Khanyaghma, Pedram Azimzadeh, Afsaneh Sharifian, and Mohammad Reza Zali, 7,“Interleukin-16 Gene Polymorphisms Are Considerable Host Genetic Factors for Patients’ Susceptibility to Chronic Hepatitis B Infection”,Volume 2014 (2014), Article ID 790753.
   6. Jason Brwle, “SVM for machine leaning”,machine learning algorithm,april 2016.
   7. Segal M. Medicare Part D Utilization and Spending on Hepatitis C Virus (HCV) Medications. Centers for Medicare & Medicaid. Office of Enterprise Data and 2015.
   8. Chirikov VV, Shaya FT, Howell CD. Contextual analysis of determinants of late diagnosis of hepatitis C virus infection in medicare patients. Hepatology. Mar 7 2015.
   9. Meckley L, Wang Z, Miyasato G, Scaife J, Sanchez H. Medicare Hepatitis C Patients: Are patients under 65 different? Poster Presentation.ISPOR 19th International Meeting, Montreal, Canada, June 2014. 2014;
   10. Hong Bo Li, Wei Wang, Hong Wei Ding, Jin Donh, ”Trees Weighting Random Forest Method for Classifying High- Dimensional Noisy Data”, IEEE 7th International Conference, Publication Year: 2010,pages:160-163.
   11. Min Ja Kim,Dong Jin Suh, “Profile of Serum Bile Acids in Liver Disease”, korrean J intern med,PMC.
   12. M .Mostafa , E. Behairy , M. Azza , A. Sameh , and E.Ehab , “Serum Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 (ITIH4) in Children with Chronic Hepatitis C: Relation to Liver Fibrosis and Viremia”, Volume 2014